Check Cap Ltd (CHEK) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Check Cap Ltd  (NASDAQ: CHEK)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Check Cap Ltd's ROA from the fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Check Cap Ltd's ROA in the fourth quarter of 2025?
Check Cap Ltd achieved a return on average assets (ROA) of 20.47 % in its fourth quarter of 2025, this is above CHEK's average return on assets of -621.57%.
Check Cap Ltd assets over the 12 months ending in its fourth quarter of 2025 are valued at $20 million

ROA has improved compared to 0.42% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector 19 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 84.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Total Assets Change -99.72 % -30.69 % -90.81 % -44.07 % 49698.72 %
Y / Y Net Income Change -76.43 % - - - -8.06 %
Net Income (TTM) in million 4 18 18 11 6
Return On Assets (TTM) 20.47 % 0.42 % 0.42 % 0.25 % 0.15 %
CHEK's Total Ranking # 84 # # # # 5749
Total Assets (TTM) in million 47 14 6 14 16,684
Seq. Total Assets Change 236.83 % 142.77 % -58.81 % -99.92 % 82532.82 %
Seq. Net Income Change - - - - -

CHEK's 5 Years Annual ROA >> Back to CHEK Management Effectiveness >> Compare CHEK ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 1
Sector # 20
Overall # 80

Return On Assets Statistics
High Average Low
146.74 %
-621.57 %
-6670.82 %
(Dec 31 2019)   (Dec 31 2024)





Financial Statements
Check Cap Ltd's Assets $ 47 million CHEK's Balance sheet
Check Cap Ltd's Income $ 4 million Quarterly CHEK's Income Statement
CHEK's Income by Division See CHEK's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -99.72 % 26500.07 % -13.9 % 34.15 % 174.66 %
Total Assets in million 47 16,684 63 73 54
Y / Y Net Income Change - - - - 24.24 %
Net Income in million 4 -25 -18 -19 17
Annual Return On Assets 8.78 % -0.15 % -28.01 % -26.23 % 31.68 %

CHEK's 5 Years Annual ROA >> Back to CHEK Management Effectiveness >> Compare CHEK ROA to its Competitors



Comment on CHEK's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 8.78 % compared to prior year, due to annual net income growth of % to $4.14 million, and due to decline of value in Check Cap Ltd's assets by -99.72 % to $47.13 million, compared to $47.13 a year before.


More Return On Assets Ratios
CHEK's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CHEK's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CHEK's Competitors
Subscribers only: Roa for Check Cap Ltd's Suppliers
Subscribers only: Return On Assets for CHEK's Customers

You may also want to know
CHEK's Roi CHEK's Inventory Turnover Ratio CHEK's Growth Rates CHEK's Dividend Comparisons
CHEK's Profitability Ratios CHEK's Asset Turnover Ratio CHEK's Dividend Growth
CHEK's Roe CHEK's Valuation Ratios CHEK's Financial Strength Ratios CHEK's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Biocryst Pharmaceuticals Inc   55.61 %
Check Cap Ltd  55.30 %
Advanced Biomed Inc.  53.63 %
Enlivex Therapeutics Ltd  53.10 %
Tg Therapeutics Inc   51.88 %
Aurinia Pharmaceuticals Inc   50.24 %
Pulmatrix Inc   48.84 %
Earth Science Tech Inc   45.81 %
Q32 Bio Inc   45.06 %
Coherus Oncology inc   42.39 %
Elite Pharmaceuticals Inc   41.21 %
Alpha Tau Medical Ltd  40.35 %
Galmed Pharmaceuticals Ltd   37.04 %
Dariohealth Corp   36.94 %
Abeona Therapeutics Inc   35.76 %
Novavax inc   35.32 %
Medinotec Inc   34.18 %
Zevra Therapeutics Inc   33.84 %
Oramed Pharmaceuticals Inc  33.67 %
Idexx Laboratories Inc  31.91 %
Acadia Pharmaceuticals Inc   29.77 %
Newgenivf Group Limited  29.73 %
Hutchmed china Limited  26.11 %
Petros Pharmaceuticals inc   26.04 %
Adma Biologics Inc   25.98 %
Theravance Biopharma inc   25.35 %
Ptc Therapeutics inc   25.21 %
Qhslab Inc   25.12 %
Medpace Holdings Inc   25.07 %
Mettler toledo International Inc   25.07 %

Date modified: 2026-07-07T09:51:03+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.